Evidence map›Paper›PMID 33042968›Full record

ArticleFrontiers in bioengineering and biotechnology2020

Scalable Biomimetic Coaxial Aligned Nanofiber Cardiac Patch: A Potential Model for "Clinical Trials in a Dish".

Naresh Kumar, Divya Sridharan, Arunkumar Palaniappan, Julie A Dougherty, Andras Czirok, Dona Greta Isai, Muhamad Mergaye, Mark G Angelos, Heather M Powell, Mahmood Khan

Open access · goldAbstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Living Nanofiber-Enabled Cardiac Patches for Myocardial Injury.JACC. Basic to translational science · 2025
    Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Naresh KumarDepartment of Emergency Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, United States.
Divya SridharanDepartment of Emergency Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, United States.
Arunkumar PalaniappanDepartment of Emergency Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, United States.
Julie A DoughertyDepartment of Emergency Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, United States.
Andras CzirokDepartment of Anatomy and Cell Biology, University of Kansas Medical Center, Kansas City, KS, United States.
Dona Greta IsaiDepartment of Biomedical Engineering, The Ohio State University, Columbus, OH, United States.
Muhamad MergayeDepartment of Emergency Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, United States.
Mark G AngelosDepartment of Emergency Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, United States.
Heather M PowellDepartment of Biomedical Engineering, The Ohio State University, Columbus, OH, United States.
Mahmood KhanDepartment of Emergency Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, United States.
The Ohio State University Wexner Medical Center · USShriners Hospitals for Children - Cincinnati · USThe Ohio State University · USUniversity of Kansas Medical Center · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Jennifer A. Woyach · 1985 to 2026
$132.3M
Biomimetic cardiac patch capable of rapid angiogenesisR01HL136232 · NHLBI · OHIO STATE UNIVERSITY · PI KHAN, MAHMOOD · 2017 to 2021
$2.8M
Morphogenetic Tissue Movements in Early EmbryosR01GM102801 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI CZIROK, ANDRAS · 2014 to 2017
$1.1M
NCI NIH HHS P30 CA016058NHLBI NIH HHS R01 HL136232NIGMS NIH HHS R01 GM102801
6 · The paper itself

Abstract

Recent advances in cardiac tissue engineering have shown that human induced-pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) cultured in a three-dimensional (3D) micro-environment exhibit superior physiological characteristics compared with their two-dimensional (2D) counterparts. These 3D cultured hiPSC-CMs have been used for drug testing as well as cardiac repair applications. However, the fabrication of a cardiac scaffold with optimal biomechanical properties and high biocompatibility remains a challenge. In our study, we fabricated an aligned polycaprolactone (PCL)-Gelatin coaxial nanofiber patch using electrospinning. The structural, chemical, and mechanical properties of the patch were assessed by scanning electron microscopy (SEM), immunocytochemistry (ICC), Fourier-transform infrared spectroscopy (FTIR)-spectroscopy, and tensile testing. hiPSC-CMs were cultured on the aligned coaxial patch for 2 weeks and their viability [lactate dehydrogenase (LDH assay)], morphology (SEM, ICC), and functionality [calcium cycling, multielectrode array (MEA)] were assessed. Furthermore, particle image velocimetry (PIV) and MEA were used to evaluate the cardiotoxicity and physiological functionality of the cells in response to cardiac drugs. Nanofibers patches were comprised of highly aligned core-shell fibers with an average diameter of 578 ± 184 nm. Acellular coaxial patches were significantly stiffer than gelatin alone with an ultimate tensile strength of 0.780 ± 0.098 MPa, but exhibited gelatin-like biocompatibility. Furthermore, hiPSC-CMs cultured on the surface of these aligned coaxial patches (3D cultures) were elongated and rod-shaped with well-organized sarcomeres, as observed by the expression of cardiac troponin-T and α-sarcomeric actinin. Additionally, hiPSC-CMs cultured on these coaxial patches formed a functional syncytium evidenced by the expression of connexin-43 (Cx-43) and synchronous calcium transients. Moreover, MEA analysis showed that the hiPSC-CMs cultured on aligned patches showed an improved response to cardiac drugs like Isoproterenol (ISO), Verapamil (VER), and E4031, compared to the corresponding 2D cultures. Overall, our results demonstrated that an aligned, coaxial 3D cardiac patch can be used for culturing of hiPSC-CMs. These biomimetic cardiac patches could further be used as a potential 3D

Indexed as

3D modelcardiac patchcardiovascular diseaseinduced pluripotent stem cell-derived cardiomyocytesmultielectrode array (MEA)myocardial infarctionnanofibers

Identifiers

PMID33042968
PMCPMC7525187
OpenAlexW3085117105

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.